Capital Research Global Investors 13D/13G Filings for Guardant Health, Inc. (GH)

Capital Research Global Investors 13D and 13G filings for Guardant Health, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-02-13
3:32 pm
Sale		 2023-02-14 13G Guardant Health, Inc.
GH		 Capital Research Global Investors 2,001,782
2.000%		 -5,925,920decrease
(-74.75%)		 Filing
2022-02-11
12:22 pm
Purchase		 2022-02-14 13G Guardant Health, Inc.
GH		 Capital Research Global Investors 7,927,702
7.800%		 7,927,702increase
(New Position)		 Filing